Article Information
History
- November 10, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Brynn Levy1,*,
- Linda B. Baughn2,
- Scott Chartrand3,
- Brandon LaBarge3,
- David Claxton4,
- Alan Lennon5,
- Yassmine Akkari6,
- Claudia Cujar1,
- Ravindra Kolhe7,
- Kate Kroeger8,
- Beth Pitel2,
- Nikhil Sahajpal7,
- Malini Sathanoori5,
- George Vlad1,
- Lijun Zhang3,
- Min Fang8,
- Rashmi Kanagal-Shamanna9 and
- James Broach3
- 1Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY
- 2Department of Laboratory Medicine and Pathology, Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN
- 3Department of Biochemistry and Molecular Biology, Pennsylvania State University Hershey Medical Center, Hershey, PA
- 4Department of Hematological Oncology, PennState Health, Hershey, PA
- 5PathGroup, Nashville, TN
- 6Cytogenetics and Molecular Pathology, Legacy Health, Portland, Oregon
- 7Department of Pathology, Medical College of Georgia at Augusta University, Augusta, GA
- 8Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
- 9Department of Hematopathology, The University of Texas MD Anderson Cancer Center
- ↵*Corresponding author; email: bl2185{at}cumc.columbia.edu
Posted November 10, 2020.
A National Multicenter Evaluation of the Clinical Utility of Optical Genome Mapping for Assessment of Genomic Aberrations in Acute Myeloid Leukemia
